About this trial
High positive end-expiratory pressure (PEEP) levels required to achieve clinical benefits may increase ICP and reduce cerebral perfusion pressure (CPP) in patients at risk of intracranial hypertension.
However, individualizing ventilation parameters is essential for each patient. Among protective ventilation strategies, PEEP is key to preventing alveolar collapse. The PEEP level that minimizes alveolar collapse while avoiding overdistension of the pulmonary parenchyma is known as the Best PEEP. This study aims to evaluate the application of Best PEEP in cranial neurosurgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA classification I-III.
Elective cranial neurosurgery.
Disqualifiers
ASA classification IV or higher.
Documented intracranial hypertension.
Severe pulmonary disease (e.g., asthma, COPD).
Emergency surgery.
Trial population
Patients with intracranial disease undergoing elective intracranial surgery
Trial design
Cohort
Prospective
Treatments tested in this trial
Subdural pressure measurement
Procedure/SurgerySubdural intracranial pressure (SDIP) will observed during an alveolar recruitment maneuver and best PEEP titatration. SDIP will be measured while mechanical ventilation is maintained using the identified best PEEP.
Treatment groups
Trial outcomes
Primary outcomes
Subdural intracranial pressure (sICP) mmHg
Change in sICP during an alveolar recruitment maneuver (ARM)
Secondary outcomes
Pulmonary mechanics parameters
To describe pulmonary mechanics parameters, including plateau pressure (cmH2O) and driving pressure.(cmH2O)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: